![]() |
市場調查報告書
商品編碼
2088682
人工智慧遠端患者監護市場:2026-2032年全球市場預測(按組件、技術、設備類型、交付方式、服務類型、應用和最終用戶分類)Artificial Intelligence in Remote Patient Monitoring Market by Component, Technology, Device Type, Mode Of Delivery, Service Type, Application, End User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,用於遠端患者監護的人工智慧 (AI) 市場將成長至 116.6 億美元,複合年成長率為 26.47%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 22.5億美元 |
| 預計年份:2026年 | 28.7億美元 |
| 預測年份 2032 | 116.6億美元 |
| 複合年成長率 (%) | 26.47% |
遠端患者監護(RPM)中的人工智慧正在將互聯醫療從間歇性測量轉變為持續的、數據驅動的臨床管理。推動其應用的因素包括慢性病負擔加重、人口老化、醫院容量緊張、醫療專業人員人手不足以及連網醫療設備、穿戴式裝置、家庭診斷和虛擬醫療平台的普及。
需求並非空穴來風。世界衛生組織(世衛組織)的數據顯示,每年約有4,100萬人死於非傳染性疾病,佔全球死亡總數的74%。美國疾病管制與預防中心(CDC)也指出,美國十分之六的成年人至少患有一種慢性疾病。人工智慧驅動的遠端患者監測(RPM)能夠幫助臨床醫生從即時和縱向數據中識別風險徵兆,從而支持早期療育,並在循環系統疾病、糖尿病、呼吸系統疾病、孕產婦健康、腫瘤、復健和急性後期監測等領域建立個人化的護理路徑。
遠端患者監護(RPM)領域正從以設備為中心的數據收集轉向以智慧主導的護理協調。傳統的RPM系統著重於採集血壓、血糖值、血氧飽和度、心率、體重、體溫、睡眠和活動量等數據。下一階段將引入機器學習、預測分析、自然語言處理、電腦視覺和邊緣人工智慧等技術,以檢測病情惡化模式、確定警報優先順序、匯總患者狀態並減輕醫護人員的負擔。
人工智慧正在對遠端患者監護的整個價值鏈產生累積影響。在患者層面,人工智慧透過分析長期趨勢而非孤立的測量數據,幫助及早發現風險。在醫療服務提供者層面,人工智慧能夠根據患者病情嚴重程度篩選和分層大量監護數據,將需要關注的警報傳輸給相應的醫療團隊,並支援更持續的追蹤。在保險公司和醫療系統層面,人工智慧能夠加強人群健康管理,減少不必要的醫療資源消耗,並促進以價值為導向的醫療保健模式的實施。
北美憑藉其成熟的數位醫療基礎設施、完善的遠端患者監護機制、FDA對人工智慧醫療設備的監管,以及醫療系統、技術開發商、保險公司和大學附屬醫院的積極參與,仍然是人工智慧在遠距病患監護領域應用的領先中心。在歐洲,互聯醫療、遠距監護、數位療法以及在GDPR和歐盟醫療設備法規下採用以隱私為中心的策略正在取得進展,同時各國醫療系統也日益重視虛擬病房、居家醫院模式和居家慢性病照護。
在東協地區,以行動優先的醫療服務模式、慢性病盛行率的上升以及政府主導的數位化醫療舉措,正在推動新加坡、印尼、泰國、馬來西亞、越南和菲律賓等市場中用於遠端患者監護(RPM)的人工智慧技術發展。在海灣合作理事會(GCC)地區,受國家轉型計劃、大規模醫療投資以及糖尿病、心血管疾病和復健護理等領域對遠距慢性病管理需求的推動,重症患者的虛擬醫療和智慧醫院生態系統發展更為迅速。
美國正透過保險報銷、保險公司與醫療服務提供者的夥伴關係、先進的醫院網路以及獲得FDA已通過核准的數位醫療創新,引領遠距病患監護(RPM)的商業化進程。在加拿大,省級虛擬醫療計畫、偏遠地區的醫療服務需求以及慢性病管理的優先事項推動了遠距病患監護的普及。同時,墨西哥和巴西正在擴展互聯醫療服務,以改善患者獲得專科醫生服務的機會、後續觀察高血壓和糖尿病,並增強醫療服務的連續性。在歐洲,英國正在擴展虛擬病房和由英國國家醫療服務體系(NHS)支持的數位醫療路徑。德國擁有強大的醫療技術基礎設施和強勁的數位醫療政策發展勢頭。法國、義大利和西班牙正透過國家和地區層面的醫療模式推動遠距監護的發展。在俄羅斯,國家數位醫療的現代化以及當地的醫療服務需求推動了遠距病患監護的普及。
產業領導者應優先考慮經臨床檢驗的人工智慧模型、工作流程整合和可衡量的結果,而非部署獨立設備。最有效的策略是將互聯感測器、病人參與工具、自動分診、與電子健康記錄(EHR) 的整合、報銷方案、遠距護理協議和多學科護理團隊結合。
本執行摘要採用二手研究框架編寫,整合了公開可用的證據,包括來自衛生當局、監管機構、同行評審文獻、數位健康政策出版物、標準化機構和行業資訊披露的資訊。主要資訊來源世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國食品藥物管理局(FDA)、經濟合作暨發展組織(OECD)、電訊(ITU)、各國衛生組織以及經認可的臨床和技術標準化機構的數據和指南。
人工智慧正成為遠端患者監護的關鍵基礎,它將連續的患者數據轉化為可操作的臨床見解。其潛力不僅限於資料收集,還能在各種醫療保健環境中(包括家庭護理、門診護理、復健護理和慢性病護理)進行預測、優先排序、個人化治療和可擴展的護理協調。
The Artificial Intelligence in Remote Patient Monitoring Market is projected to grow by USD 11.66 billion at a CAGR of 26.47% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 2.25 billion |
| Estimated Year [2026] | USD 2.87 billion |
| Forecast Year [2032] | USD 11.66 billion |
| CAGR (%) | 26.47% |
Artificial intelligence in remote patient monitoring (AI in RPM) is moving connected care from episodic measurement to continuous, data-driven clinical oversight. Adoption is being shaped by a rising chronic disease burden, aging populations, hospital capacity pressure, clinician workforce constraints, and broader use of connected medical devices, wearables, home diagnostics, and virtual care platforms.
The need is measurable: the World Health Organization reports that noncommunicable diseases account for about 41 million deaths annually, or 74% of global deaths, while the U.S. Centers for Disease Control and Prevention states that 6 in 10 U.S. adults live with at least one chronic disease. AI-enabled RPM helps clinicians identify risk signals from real-time and longitudinal data, support earlier intervention, and personalize care pathways across cardiology, diabetes, respiratory disease, maternal health, oncology, rehabilitation, and post-acute monitoring.
The remote patient monitoring landscape is shifting from device-centric data capture to intelligence-led care orchestration. Traditional RPM systems focused on collecting blood pressure, glucose, oxygen saturation, heart rhythm, weight, temperature, sleep, and activity data. The next phase adds machine learning, predictive analytics, natural language processing, computer vision, and edge AI to detect deterioration patterns, prioritize alerts, summarize patient status, and reduce clinician burden.
Three structural shifts are redefining competitive advantage: interoperability with electronic health records, clinically validated algorithms, and reimbursement-aligned virtual care operations. Standards such as HL7 FHIR, expanding broadband and 5G connectivity, cloud-native analytics, and software-as-a-medical-device oversight are making AI-powered RPM more scalable, but success increasingly depends on evidence generation, cybersecurity, explainability, equitable data representation, and integration into clinical workflows.
Artificial intelligence has a cumulative impact across the remote patient monitoring value chain. At the patient level, AI supports earlier identification of risk by analyzing longitudinal trends rather than isolated readings. At the provider level, it helps filter high-volume monitoring data, stratify patients by acuity, route actionable alerts to the right care team, and support more consistent follow-up. At the payer and health-system level, it strengthens population health management, avoidable utilization reduction, and value-based care execution.
The impact is strongest when AI models are trained on representative data, validated in real-world settings, monitored after deployment, and governed by clear clinical protocols. Evidence from telehealth and RPM programs shows that remote monitoring can improve chronic disease management when paired with care coordination; AI extends this value by making monitoring more predictive, scalable, and personalized while requiring strong safeguards for bias, privacy, cybersecurity, transparency, and patient safety.
North America remains a leading adoption hub for AI in remote patient monitoring due to mature digital health infrastructure, established virtual care reimbursement pathways, FDA oversight for AI-enabled medical devices, and strong participation from health systems, technology developers, payers, and academic medical centers. Europe is advancing through connected care, telemonitoring, digital therapeutics, and privacy-focused deployment under GDPR and the EU Medical Device Regulation, while national health systems increasingly prioritize virtual wards, hospital-at-home models, and home-based chronic care.
Asia-Pacific is one of the most dynamic regions for AI-enabled RPM, supported by large patient populations, rapid smartphone adoption, aging demographics in Japan, South Korea, and China, and digital health expansion in India and Southeast Asia. Latin America is gaining traction as public and private providers use RPM to extend specialist access, particularly in Brazil and Mexico, where chronic disease follow-up and geographic access gaps remain important drivers. The Middle East is investing in smart hospitals, cloud-enabled health records, and national digital health strategies, especially across Gulf economies, while Africa's opportunity is tied to mobile-first models, community health networks, and scalable monitoring for underserved populations despite infrastructure, affordability, and connectivity barriers.
Within ASEAN, AI-enabled RPM is being shaped by mobile-first healthcare access, rising chronic disease prevalence, and government-backed digital health initiatives in markets such as Singapore, Indonesia, Thailand, Malaysia, Vietnam, and the Philippines. The GCC is advancing faster in high-acuity virtual care and smart hospital ecosystems, supported by national transformation programs, strong healthcare investment, and demand for remote chronic disease management across diabetes, cardiovascular disease, and post-acute care.
The European Union emphasizes regulated, interoperable, and privacy-preserving deployment, making clinical validation, cross-border data governance, and harmonized digital health standards central to adoption. BRICS economies represent substantial implementation scale because of large populations, expanding middle classes, and growing digital health infrastructure, though adoption varies by reimbursement maturity, public health capacity, and regional connectivity. G7 countries lead in clinical research, reimbursement experimentation, regulatory frameworks, and AI governance, while NATO member states increasingly view secure digital health infrastructure, cybersecurity, and resilient remote care capability as part of broader health-system readiness.
The United States leads commercialization through RPM reimbursement, payer-provider partnerships, advanced hospital networks, and FDA-cleared digital health innovation. Canada's adoption is supported by provincial virtual care programs, rural and remote access needs, and chronic disease management priorities, while Mexico and Brazil are expanding connected care to improve specialist reach, hypertension and diabetes follow-up, and continuity of care. In Europe, the United Kingdom is scaling virtual wards and NHS-backed digital pathways; Germany benefits from strong medtech infrastructure and digital health policy momentum; France, Italy, and Spain are advancing telemonitoring through national and regional care models; and Russia's adoption is influenced by domestic digital health modernization and regional access needs.
China is scaling AI-enabled healthcare through hospital digitization, large connected health ecosystems, and chronic disease demand. India combines high population need, expanding telemedicine, smartphone penetration, and cost-sensitive innovation, creating strong long-term potential for AI-assisted RPM. Japan's aging society makes home monitoring, fall risk detection, cardiovascular monitoring, and predictive care highly relevant, while South Korea's advanced connectivity and medical technology ecosystem support rapid deployment. Australia is using remote monitoring to address rural distance, chronic care management, Indigenous health access gaps, and home-based healthcare delivery.
Industry leaders should prioritize clinically validated AI models, workflow integration, and measurable outcomes rather than standalone device deployment. The strongest strategies combine connected sensors, patient engagement tools, triage automation, EHR integration, reimbursement design, remote nursing protocols, and multidisciplinary care teams.
Executives should invest in explainable AI, cybersecurity, regulatory readiness, algorithm monitoring, and health equity safeguards. Partnerships with hospitals, payers, device manufacturers, cloud infrastructure providers, clinical researchers, and validation networks can accelerate adoption. Leaders should also track outcomes such as alert burden, escalation accuracy, adherence, time to intervention, emergency visits, readmissions, clinician time saved, patient activation, and patient satisfaction to prove value at scale.
This executive summary is developed using a secondary-research framework that synthesizes publicly available evidence from healthcare authorities, regulatory agencies, peer-reviewed literature, digital health policy publications, standards bodies, and industry disclosures. Core inputs include data and guidance from organizations such as the World Health Organization, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, OECD, International Telecommunication Union, national health agencies, and recognized clinical and technology standards bodies.
The methodology evaluates market drivers, technology adoption patterns, regulatory conditions, reimbursement dynamics, regional healthcare infrastructure, connectivity readiness, clinical evidence, and competitive implications. Insights are triangulated across multiple credible sources to avoid reliance on single-point claims, with emphasis on verified indicators such as chronic disease prevalence, aging demographics, broadband and mobile access, medical device regulation, AI governance, cybersecurity requirements, and digital health implementation trends.
Artificial intelligence is becoming a defining layer of remote patient monitoring by converting continuous patient data into actionable clinical intelligence. The opportunity is not limited to data capture; it lies in prediction, prioritization, personalization, and scalable care coordination across home, ambulatory, post-acute, and chronic care settings.
As health systems face chronic disease growth, workforce shortages, aging populations, health equity gaps, and cost pressure, AI-enabled RPM offers a practical pathway to shift more care into the home without losing clinical visibility. Organizations that combine evidence-based AI, trusted data governance, interoperable platforms, secure infrastructure, and patient-centered design will be best positioned to lead the next phase of connected healthcare.